AnaptysBio
ANAB
ANAB
136 hedge funds and large institutions have $963M invested in AnaptysBio in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 42 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.22% more ownership
Funds ownership: 100.67% → 100.88% (+0.22%)
10% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 42
Holders
136
Holding in Top 10
3
Calls
$1.51M
Puts
–
Top Buyers
| 1 | +$23M | |
| 2 | +$8.94M | |
| 3 | +$6.08M | |
| 4 |
N
Natixis
Paris,
France
|
+$5.53M |
| 5 |
EP
Eversept Partners
New York
|
+$3.63M |
Top Sellers
| 1 | -$14M | |
| 2 | -$9.91M | |
| 3 | -$9.07M | |
| 4 |
Millennium Management
New York
|
-$3.98M |
| 5 |
SG Americas Securities
New York
|
-$3.52M |